Int. J. Mol. Sci. 2013, 14(10), 20019-20036; doi:10.3390/ijms141020019
Review

Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum

1 Genetics and Physiopathology of Epithelial Cancers, INSERM U 1081-CNRS UMR 7284-UNS, Institute for Research on Cancer and Aging, Nice, Medical school, 28 Avenue de Valombrose, 06107 Nice Cedex 2, France 2 Oréal Research and Innovation, 92217 Clichy, France 3 Hopital Cochin, Pavillon Tarnier, APHP, Université Paris 6, 75006 Paris, France These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 29 July 2013; in revised form: 11 September 2013 / Accepted: 17 September 2013 / Published: 9 October 2013
(This article belongs to the Special Issue Molecular Research of Epidermal Stem Cells)
PDF Full-text Download PDF Full-Text [513 KB, uploaded 9 October 2013 13:47 CEST]
Abstract: Somatic stem cells ensure tissue renewal along life and healing of injuries. Their safe isolation, genetic manipulation ex vivo and reinfusion in patients suffering from life threatening immune deficiencies (for example, severe combined immunodeficiency (SCID)) have demonstrated the efficacy of ex vivo gene therapy. Similarly, adult epidermal stem cells have the capacity to renew epidermis, the fully differentiated, protective envelope of our body. Stable skin replacement of severely burned patients have proven life saving. Xeroderma pigmentosum (XP) is a devastating disease due to severe defects in the repair of mutagenic DNA lesions introduced upon exposure to solar radiations. Most patients die from the consequences of budding hundreds of skin cancers in the absence of photoprotection. We have developed a safe procedure of genetic correction of epidermal stem cells isolated from XP patients. Preclinical and safety assessments indicate successful correction of XP epidermal stem cells in the long term and their capacity to regenerate a normal skin with full capacities of DNA repair.
Keywords: stem cells; skin; epidermis; cancer; DNA repair; genetic correction; xeroderma pigmentosum

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Rouanet, S.; Warrick, E.; Gache, Y.; Scarzello, S.; Avril, M.-F.; Bernerd, F.; Magnaldo, T. Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum. Int. J. Mol. Sci. 2013, 14, 20019-20036.

AMA Style

Rouanet S, Warrick E, Gache Y, Scarzello S, Avril M-F, Bernerd F, Magnaldo T. Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum. International Journal of Molecular Sciences. 2013; 14(10):20019-20036.

Chicago/Turabian Style

Rouanet, Sophie; Warrick, Emilie; Gache, Yannick; Scarzello, Sabine; Avril, Marie-Françoise; Bernerd, Françoise; Magnaldo, Thierry. 2013. "Genetic Correction of Stem Cells in the Treatment of Inherited Diseases and Focus on Xeroderma Pigmentosum." Int. J. Mol. Sci. 14, no. 10: 20019-20036.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert